scardraven
liked
The Global Paper Trading Challenge has been underway for 2 weeks now, and we're thrilled to have passionate participants from around the globe!
In the U.S. region, more than 2500 participants have achieved positive weekly virtual gains. Three popular stocks traded in our Challenge last week? $Iterum Therapeutics (ITRM.US)$, $Upexi (UPXI.US)$, and $NWTN Inc (NWTN.US)$.
Spotlight on Our Top Participants
Last week's top thr...
+4
86
67
scardraven
liked
The Global Paper Trading Challenge has been underway for a week now, and we're thrilled to have over 75,000 participants from around the globe!
In the U.S. region, more than 85 participants have achieved weekly virtual gains exceeding 10%. The most popular stock traded in our Challenge last week? $Bright Minds Biosciences (DRUG.US)$, a pharmaceutical company that just received FDA approval for its new drug. This week, $GRI Bio (GRI.US)$ is curren...
+4
506
79
scardraven
commented on
$Kintara Therapeutics (KTRA.US)$ are there any updates on the RS?
4
scardraven
liked and commented on
Do you have difficulties navigating the app, especially if you're new to moomoo? Do you feel frustrated while choosing the right tool to enhance your trading decisions?
At moomoo Learn, we're always listening to user feedback and striving to help you trade with ease and efficiency. We understand that moomoo’s numerous features can sometimes feel overwhelming. Today, we’re excited to walk you through some useful but often overlooked guides. By th...
At moomoo Learn, we're always listening to user feedback and striving to help you trade with ease and efficiency. We understand that moomoo’s numerous features can sometimes feel overwhelming. Today, we’re excited to walk you through some useful but often overlooked guides. By th...
+2
689
254
scardraven
liked
$Kintara Therapeutics (KTRA.US)$ needed to say this again for benefits of those who are novice as regards biotech reverse Mergers that are saying they are voting or voted against RS, let me tell u this no company with share under a buck will not go through RS for the following purposes
1. to meet nasdaq listing requirements of above 4$
2.They have to reduce the total shares outstanding so the new company can start with reasonable OS so there won't be much OS Incase they want to raise funds in t...
1. to meet nasdaq listing requirements of above 4$
2.They have to reduce the total shares outstanding so the new company can start with reasonable OS so there won't be much OS Incase they want to raise funds in t...
2
scardraven
commented on
$Theriva Biologics (TOVX.US)$ garbage 🗑
6
scardraven
commented on
$American Shared Hospital Services (AMS.US)$ 5 coming soon
2
scardraven
liked
shorts are all over the market in every stock
notice the indices are at all time highs but the stocks in your portfolio are bleeding
welcome to 2021, post gamestop reality
I have a lot of theories for this but i will reserve it for another day
funds and institutions are shorting every ticker in an organized manner
better average down or take a short position yourself. i don’t short stocks - i don’t believe in it for ethical reasons. but i average down
$Jiuzi (JZXN.US)$
notice the indices are at all time highs but the stocks in your portfolio are bleeding
welcome to 2021, post gamestop reality
I have a lot of theories for this but i will reserve it for another day
funds and institutions are shorting every ticker in an organized manner
better average down or take a short position yourself. i don’t short stocks - i don’t believe in it for ethical reasons. but i average down
$Jiuzi (JZXN.US)$
37
1
scardraven
liked
$Sidus Space (SIDU.US)$ $2M contract, Loss per share improved by 95% and now Fintel reports no short shares left. Can we say squeeze? Please?
2
1
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)